Pulmonary rehabilitation in COPD according to global initiative for chronic obstructive lung disease categories

Respiratory Care

Volumn 61, Issue 10, 2016, Pages 1331-1340

  Alfarroba, Sara ^a   Rodrigues, Fátima ^a,b   Papoila, Ana Luísa ^b,c   Santos, Ana Filipe ^a   Morais, Luísa ^a  

^a HOSPITAL PULIDO VALENTE   (Portugal)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c Center of Statistics Applications of Lisbon University CEAUL   (Portugal)

Author keywords

6 min walking distance; Constant work rate; COPD; COPD categories; Mahler s index; Pulmonary rehabilitation; Quality of life; St George Respiratory Questionnaire

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; EMERGENCY WARD; FEMALE; HUMAN; HYPERTENSION; LIFE EXPECTANCY; MALE; MUSCLE EXERCISE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUALITY OF LIFE; SLEEP DISORDERED BREATHING; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TRAINING; AGED; CLASSIFICATION; COMPLICATION; DISEASE COURSE; DYSPNEA; EVALUATION STUDY; EXERCISE TOLERANCE; MIDDLE AGED; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RESPIRATORY CARE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; DISEASE PROGRESSION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84989177894     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.04414     Document Type: Article

References (46)

1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. Available from: http://www.goldcopd.org.
2. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188(8):e13-e64.
3. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997;10(2):417-423.
4. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62(2):115-120.
5. Gale NS, Duckers JM, Enright S, Cockcroft JR, Shale DJ, Bolton CE. Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulm Med 2011;11:20.
6. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2008. Available from: http://www.goldcopd.org.
7. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;(2):CD003793.
8. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348(9035):1115-1119.
9. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med 2003;18(3): 213-221.
10. Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Mölken MP. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J 2010;35(1):79-87.
11. Bolton CE, Blakey JD, Morgan MD. The British Thoracic Society guideline on pulmonary rehabilitation in adults: your opinion is noted. Thorax 2014;69(4):388-389.
12. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med 2009;103(7):1070-1075.
13. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 2006;27(4):788-794.
14. Man WD, Grant A, Hogg L, Moore J, Barker RD, Moxham J. Pulmonary rehabilitation in patients with MRC Dyspnoea Scale 2. Thorax 2011;66(3):263.
15. Scott AS, Baltzan MA, Fox J, Wolkove N. Success in pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Can Respir J 2010;17(5):219-223.
16. Jácome C, Marques A. Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care 2014;59(4):588-594.
17. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999;160(4):1248-1253.
18. McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J 1976;1(6013): 822-823.
19. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49(2):162-170.
20. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2(5147):257-266.
21. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.
22. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
23. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186(2):155-161.
24. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.
25. Vivodtzev I, Gagnon P, Pepin V, Saey D, Laviolette L, Brouillard C, Maltais F. Physiological correlates of endurance time variability during constant-workrate cycling exercise in patients with COPD. PLoS One 2011;6(2):e17007.
26. Borel B, Provencher S, Saey D, Maltais F. Responsiveness of various exercise-testing protocols to therapeutic interventions in COPD. Pulm Med 2013;2013:410748.
27. Holland AE, Nici L. The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(4):335-336.
28. Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schünemann HJ. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008;32(3):637-643.
29. Puente-Maestu L, Villar F, de Miguel J, Stringer WW, Sanz P, Sanz ML, et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J 2009;34(2):340-345.
30. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85(6): 751-758.
31. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002;19(3):398-404.
32. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and St George Respiratory Questionnaire in COPD patients participating in pulmonary rehabilitation COPD 2012;9(1):12-15.
33. Barakat S, Michele G, George P, Nicole V, Guy A. Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3(1):155-162.
34. van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van Mölken MP, Schols AM. Short-and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65(1):7-13.
35. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355(9201):362-368.
36. de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002;121(4):1092-1098.
37. Jones P, Lareau S, Mahler DA. Measuring the effects of COPD on the patient. Respir Med 2005;99(Suppl B):S11-S18.
38. Román M, Larraz C, Gómez A, Ripoll J, Mir I, Miranda EZ, et al. Efficacy of pulmonary rehabilitation in patients with moderate chronic obstructive pulmonary disease: a randomized controlled trial. BMC Fam Pract 2013;14:21.
39. Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, Müllerova H, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J 2013; 42(3):636-646.
40. Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Rutten-van Mölken MP. Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study. Prim Care Respir J 2014;23(1):30-37.
41. Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluna JJ, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest 2013;143(3):694-702.
42. Soriano JB, Rodríguez MR. A golden goal in 2010, and another GOLD in 2014 in primary care, or vice versa. Prim Care Respir J 2014;23(1):5-6.
43. Franssen FM, Rochester CL. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter? Eur Respir Rev 2014; 23(131):131-141.
44. Carreiro A, Santos J, Rodrigues F. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease. Rev Port Pneumol 2013;19(3): 106-113.
45. Paz-Díaz H, Montes de Oca M, López JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2007; 86(1):30-36.
46. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003;84(8): 1154-1157.